| Trademark Snap Shot ITU Unit Action (Table presents the data on ITU Unit Action) |
|||
OVERVIEW |
|||
| SERIAL NUMBER | 88823358 | FILING DATE | 03/05/2020 |
| REG NUMBER | 0000000 | REG DATE | N/A |
| REGISTER | PRINCIPAL | MARK TYPE | TRADEMARK |
| INTL REG # | N/A | INTL REG DATE | N/A |
| TM ATTORNEY | GOLD, BARBARA A |
L.O. ASSIGNED | 106 |
PUB INFORMATION |
|||
| RUN DATE | 09/30/2021 | ||
| PUB DATE | 09/29/2020 | ||
| STATUS | 731-SECOND EXTENSION - GRANTED | ||
| STATUS DATE | 09/28/2021 | ||
| LITERAL MARK ELEMENT | SUNLENCA | ||
| DATE ABANDONED | N/A | DATE CANCELLED | N/A |
| SECTION 2F | NO | SECTION 2F IN PART | NO |
| SECTION 8 | NO | SECTION 8 IN PART | NO |
| SECTION 15 | NO | REPUB 12C | N/A |
| RENEWAL FILED | NO | RENEWAL DATE | N/A |
| DATE AMEND REG | N/A | ||
FILING BASIS |
|||||
| FILED BASIS | CURRENT BASIS | AMENDED BASIS | |||
| 1 (a) | NO | 1 (a) | NO | 1 (a) | NO |
| 1 (b) | YES | 1 (b) | YES | 1 (b) | NO |
| 44D | YES | 44D | NO | 44D | NO |
| 44E | NO | 44E | YES | 44E | NO |
| 66A | NO | 66A | NO | ||
| NO BASIS | NO | NO BASIS | NO | ||
MARK DATA |
|
| STANDARD CHARACTER MARK | YES |
| LITERAL MARK ELEMENT | SUNLENCA |
| MARK DRAWING CODE | 4-STANDARD CHARACTER MARK |
| COLOR DRAWING FLAG | NO |
CURRENT OWNER INFORMATION |
|
| PARTY TYPE | 20-OWNER AT PUBLICATION |
| NAME | Gilead Sciences Ireland UC |
| ADDRESS | IDA BUSINESS AND TECHNOLOGY PARK CARRIGTOHILL, CO. CORK, |
| ENTITY | 99-Unlimited Company |
| CITIZENSHIP | Ireland |
GOODS AND SERVICES |
|
| INTERNATIONAL CLASS | 005 |
| DESCRIPTION TEXT | Antiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of kidney and nephropathic diseases and disorders; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for treatment of gastrointestinal diseases and disorders |
GOODS AND SERVICES CLASSIFICATION |
|||||||
| INTERNATIONAL CLASS | 005 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
MISCELLANEOUS INFORMATION/STATEMENTS |
|
| CHANGE IN REGISTRATION | NO |
FOREIGN INFORMATION |
|
| PRIORITY CLAIMED | SEC. 44(D) ON Ireland |
| APPLICATION NO. | 201901875 |
| APPLICATION FILING DATE | 10/16/2019 |
| FOREIGN REG NO. | 262122 |
| FOREIGN REG DATE | 07/08/2020 |
| FOREIGN RNWL NUM | N/A |
| DATE OF FOREIGN RNWL | N/A |
| FOREIGN EXPIRATION | 10/15/2029 |
| FOREIGN RNWL EXPIRATION | N/A |
PROSECUTION HISTORY |
||||
| DATE | ENT CD | ENT TYPE | DESCRIPTION | ENT NUM |
| 09/30/2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 023 |
| 09/28/2021 | EX2G | S | EXTENSION 2 GRANTED | 022 |
| 09/28/2021 | EXT2 | S | EXTENSION 2 FILED | 021 |
| 09/28/2021 | EEXT | I | TEAS EXTENSION RECEIVED | 020 |
| 04/02/2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 019 |
| 03/31/2021 | EX1G | S | EXTENSION 1 GRANTED | 018 |
| 03/31/2021 | EXT1 | S | EXTENSION 1 FILED | 017 |
| 03/31/2021 | EEXT | I | TEAS EXTENSION RECEIVED | 016 |
| 11/24/2020 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 015 |
| 09/29/2020 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 014 |
| 09/29/2020 | PUBO | A | PUBLISHED FOR OPPOSITION | 013 |
| 09/09/2020 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 012 |
| 08/21/2020 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | 011 |
| 08/12/2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | 010 |
| 08/12/2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | 009 |
| 08/07/2020 | ALIE | A | ASSIGNED TO LIE | 008 |
| 07/22/2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | 007 |
| 05/28/2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | 006 |
| 05/28/2020 | GNRT | F | NON-FINAL ACTION E-MAILED | 005 |
| 05/28/2020 | CNRT | R | NON-FINAL ACTION WRITTEN | 004 |
| 05/24/2020 | DOCK | D | ASSIGNED TO EXAMINER | 003 |
| 03/11/2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 002 |
| 03/09/2020 | NWAP | I | NEW APPLICATION ENTERED IN TRAM | 001 |
CURRENT CORRESPONDENCE INFORMATION |
|
| ATTORNEY | Gretchen R. Stroud |
| CORRESPONDENCE ADDRESS | Gretchen R. Stroud GILEAD SCIENCES, INC. 333 LAKESIDE DRIVE FOSTER CITY DE 94404 |
| DOMESTIC REPRESENTATIVE | NONE |
PRIOR OWNER INFORMATION |
|
| PARTY TYPE | 10-ORIGINAL APPLICANT |
| NAME | Gilead Sciences Ireland UC |
| ADDRESS | IDA BUSINESS AND TECHNOLOGY PARK CARRIGTOHILL, CO. CORK, |
| ENTITY | 99-Unlimited Company |
| CITIZENSHIP | Ireland |